• Fund Type: Open-End Fund
  • Objective: Growth Large Cap
  • Asset Class: Equity
  • Geographic Focus: U.S.

Laudus US Large Cap Growth Fund

+ Add to Watchlist

LGILX:US

16.83 USD 0.09 0.54%

As of 09:29:30 ET on 12/26/2014.

Snapshot for Laudus US Large Cap Growth Fund (LGILX)

Year To Date: +9.50% 3-Month: +4.92% 3-Year: +20.92% 52-Week Range: 14.26 - 16.91
1-Month: +0.37% 1-Year: +10.57% 5-Year: +15.43% Beta vs RLG: 1.10

Mutual Fund Chart for LGILX

No chart data available.
  • LGILX:US 16.83
  • 1M
  • 1Y
Interactive LGILX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for LGILX

Laudus U.S. Large Cap Growth Fund is an open-end fund incorporated in the USA. The Fund aims to provide long-term capital appreciation. The Fund invests at least 80% of its assets in equity securities of U.S. large capitalization companies and up to 20% may be invested in foreign equity securities.

Inception Date: 10-14-1997 Telephone: 1-800-447-3332 Inv/Adv Shares
Managers: LAWRENCE G KEMP
Web Site: www.laudusfunds.com

Fundamentals for LGILX

NAV (on 2014-12-26) 16.83
Assets (M) (on 2014-11-28) 2,291.57
Fund Leveraged N
Minimum Investment 100.00
Minimum Subsequent Investment 0.00

Dividends for LGILX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-16) 0.43
Dividend Yield (ttm) 20.20

Fees & Expenses for LGILX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.64
Redemption Fee 2.00
12b1 Fee 0.00
Expense Ratio 0.77

Top Fund Holdings for LGILX

Filing Date: 06/30/2014
Name Position Value % of Total
Google Inc 215,336 125,900,499 5.765%
AbbVie Inc 1,589,848 89,731,021 4.109%
Apple Inc 949,461 88,233,411 4.041%
Twenty-First Century Fox Inc 2,013,355 70,769,428 3.241%
Visa Inc 334,260 70,431,925 3.225%
Facebook Inc 1,042,732 70,165,436 3.213%
Yahoo! Inc 1,968,814 69,164,436 3.167%
Union Pacific Corp 639,574 63,797,507 2.922%
Regeneron Pharmaceuticals Inc 193,301 54,601,733 2.500%
Valeant Pharmaceuticals Intern 427,504 53,916,804 2.469%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil